Rafferty Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-186,528
| Closed | -$13.4M | – | 847 |
|
|
2018
Q4 | $13.4M | Sell |
186,528
-754,936
| -80% | -$54.2M | 0.29% | 43 |
|
|
2018
Q3 | $90.3M | Buy |
941,464
+501,695
| +114% | +$48.1M | 1.4% | 12 |
|
|
2018
Q2 | $41.9M | Sell |
439,769
-1,075,212
| -71% | -$102M | 0.63% | 28 |
|
|
2018
Q1 | $133M | Buy |
1,514,981
+1,383,636
| +1,053% | +$121M | 1.97% | 9 |
|
|
2017
Q4 | $11.1M | Sell |
131,345
-105,724
| -45% | -$8.97M | 0.19% | 64 |
|
|
2017
Q3 | $20.5M | Buy |
237,069
+56,986
| +32% | +$4.93M | 0.46% | 31 |
|
|
2017
Q2 | $13.9M | Sell |
180,083
-14,270
| -7% | -$1.1M | 0.4% | 34 |
|
|
2017
Q1 | $13.5M | Sell |
194,353
-108,109
| -36% | -$7.5M | 0.3% | 33 |
|
|
2016
Q4 | $17.9M | Buy |
302,462
+186,422
| +161% | +$11M | 0.82% | 11 |
|
|
2016
Q3 | $7.69M | Sell |
116,040
-258,034
| -69% | -$17.1M | 0.28% | 25 |
|
|
2016
Q2 | $20.2M | Buy |
374,074
+244,029
| +188% | +$13.2M | 1.37% | 12 |
|
|
2016
Q1 | $6.72M | Buy |
+130,045
| New | +$6.72M | 0.37% | 31 |
|
|
2015
Q3 | – | Sell |
-12,738
| Closed | -$1.07M | – | 616 |
|
|
2015
Q2 | $1.07M | Buy |
+12,738
| New | +$1.07M | 0.07% | 204 |
|